References
- Jain KK. Future prospects for the cure of brain cancer. Technol. Cancer Res. Treat.5, 183–184 (2006).
- Newton H. Advances in strategies to improve drug delivery to brain tumors. Expert Rev. Neurother.6, 1495–1509 (2006).
- Jain KK. Nanotechnology-based drug delivery for cancer. Technol. Cancer Res. Treat.4, 311–314 (2005).
- Jain KK. Nanobiotechnology: Applications, Markets and Companies. Jain PharmaBiotech Publications, Basel, Switzerland (2007).
- Koo YE, Reddy GR, Bhojani M et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv. Drug Deliv. Rev.58, 1556–1577 (2006).
- Koziara JM, Lockman PR, Allen DD, Mumper RJ. Paclitaxel nanoparticles for the potential treatment of brain tumors. J. Control. Release99, 259–269 (2004).
- Jeong YI, Kim SH, Jung TY et al. Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J. Pharm. Sci.95, 2348–2360 (2006).
- Xie J, Wang CH. Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro. Pharm. Res.23, 1817–1826 (2006).
- Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev.47, 65–81 (2001).
- Ambruosi A, Gelperina S, Khalansky A, Tanski S, Theisen A, Kreuter J. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J. Microencapsul.23, 582–592 (2006).
- Petri B, Bootz A, Khalansky A et al. Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants. J. Control. Release117, 51–58 (2007).
- Steiniger SC, Kreuter J, Khalansky AS et al. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int. J. Cancer109, 759–767 (2004).
- Zhang Y, Sun C, Kohler N et al. Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomed. Microdevices6, 33–40 (2004).
- Simberg D, Duza T, Park JH et al. Biomimetic amplification of nanoparticle homing to tumors. Proc. Natl Acad. Sci. USA104, 932–936 (2007).
- Wu G, Barth RF, Yang W et al. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug. Chem.15, 185–194 (2004).
- Yang W, Barth RF, Wu G et al. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin. Cancer Res.12, 3792–3802 (2006).
- Abraham SA, Waterhouse DN, Mayer LD et al. The liposomal formulation of doxorubicin. Methods Enzymol.391, 71–97 (2005).
- Madhankumar AB, Slagle-Webb B, Mintz A et al. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Mol. Cancer Ther.5, 3162–3169 (2006).
- Mamot C, Drummond DC, Noble CO et al. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res.65, 1631–11638 (2005).
- Lopez KA, Waziri AE, Canoll PD, Bruce JN. Convection-enhanced delivery in the treatment of malignant glioma. Neurol. Res.28, 542–548 (2006).
- Saito R, Bringas JR, McKnight TR et al. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res.64, 2572–2579 (2004).
- Krauze MT, Forsayeth J, Park JW, Bankiewicz KS. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res.23, 2493–2504 (2006).
- Noble CO, Krauze MT, Drummond DC et al. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res.66, 2801–2806 (2006).
- Jordan A, Scholz R, Maier-Hauff K et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol.78, 7–14 (2006).
- Maier-Hauff K, Rothe R, Scholz R et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol.81, 53–60 (2007).
- Plotkin M, Gneveckow U, Meier-Hauff K et al.18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int. J. Hyperthermia22, 319–325 (2006).
- Reddy GR, Bhojani MS, McConville P et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res.12, 6677–6686 (2006).
- Kopelman R, Philbert M, Koo YEL et al. Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer. J. Magnetism Magnetic Mater.293, 404–410 (2005).
- Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res.66, 11878–11887 (2006).
- Yu W, Pirollo KF, Rait A et al. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. Gene Ther.11, 1434–1440 (2004).
- Reszka RC, Jacobs A, Voges J. Liposome-mediated suicide gene therapy in humans. Methods Enzymol.391, 200–208 (2005).
- Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood105, 420–425 (2005).
- Peters A, Veronesi B, Calderon-Garciduenas L et al. Translocation and potential neurological effects of fine and ultrafine particles: a critical update. Part. Fibre Toxicol.3, 13 (2006).
- Muldoon LL, Sandor M, Pinkston KE, Neuwelt EA. Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery57, 785–796 (2005).